ATXI
AVENUE THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.43
+0.00%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$56
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +48.7%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$56 | -$0.21 | Beat 99.63% | — |
| May 8, 2026 | -$56 | -$0.21 | Beat 99.63% | — |
| Mar 30, 2026 | -$56 | -$0.22 | Beat 99.61% | — |
| Nov 13, 2025 | — | -$0.21 | — | — |
| Aug 14, 2025 | — | $0.11 | — | $1.4M |
| May 15, 2025 | — | -$0.62 | — | — |
| Mar 31, 2025 | — | $1.48 | — | — |
| Nov 14, 2024 | -$0.94 | -$1.92 | Miss -104.26% | — |
| Aug 9, 2024 | -$1.05 | -$6.43 | Miss -512.38% | — |
| May 15, 2024 | -$9.00 | -$15 | Miss -71.11% | — |
| Mar 18, 2024 | -$0.10 | $42 | Beat 42210.00% | — |
| Nov 13, 2023 | -$0.26 | $4.51 | Beat 1834.62% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026